General Information
As of 02/09/2010
|
| NAV |
$12.68 |
| NAV Daily Change |
$0.07 |
| % Yield |
0 |
| % SEC Yield |
N/A |
| % YTD Return (as of 12/31/2009) |
19.47 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
6.58 |
| Net Assets (Mil $) 10/31/2009 |
116.89 |
| % Turnover 10/31/2009 |
274.00 |
Fees
|
| % Max Sales Load |
5.25 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.25 |
| % Max Management Fee |
.92 |
| % Redemption Fee |
.00 |
| % Expense Ratio |
1.65 |
Allocation
|
| Large Growth |
50.46 |
| Large Value |
.00 |
| Small Growth |
.00 |
| Small Value |
.00 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
12.86 |
| Foreign Bond |
.00 |
| High Yield Bond |
.00 |
Portfolio Information |
| Composition |
| As of 10/31/2009 |
% of Net Assets |
| Stock |
99.40 |
| Cash |
9.44 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.00 |
| Foreign Stock |
7.27 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-8.84 |
Sector / Country Weightings
|
Sector / Country Weightings
|
| As of 10/31/2009 |
% of Portfolio |
| Health |
72.14 |
| Retail Trade |
8.06 |
| Finance |
7.49 |
| Services |
4.25 |
| Industrial Cyclical |
2.75 |
| Technology |
2.50 |
| Other |
2.23 |
| Consumer Durables |
.58 |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 10/31/2009) |
% of Portfolio |
Value (Mil$) |
|
| JOHNSON & JOHNSON |
14.20 |
22.50 |
| PFIZER INC |
9.71 |
15.39 |
| ABBOTT LABORATORIES |
5.07 |
8.04 |
| BRISTOL MYERS SQUIBB CO |
4.42 |
7.01 |
| MERCK & CO |
3.98 |
6.30 |
| MEDTRONIC INC |
3.74 |
5.93 |
| WELLPOINT |
3.68 |
5.83 |
| AMGEN |
3.33 |
5.27 |
| BAXTER INTERNATIONAL |
3.22 |
5.10 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now 
|
Fund Description
|
The fund was incepted in July 1997 and is managed by Morgan Stanley Investment Advisors. The objective of the fund is to seek capital appreciation. The fund invests in common stocks of health science companies throughout the world. Income dividends are distributed annually. Capital gains, if any, are distributed in December.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
10/31/2009 |
| Total Issues |
81 |
| Avg. P/E |
24.39 |
| Avg. P/Book |
5.06 |
| Avg. EPS Growth |
14.76 |
| Avg. Market Value (Mil $) |
62,974 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.75 |
0.75 |
0.60 |
| Alpha |
4.30 |
1.71 |
6.06 |
| R Squared |
0.67 |
0.62 |
0.31 |
| Std. Dev. |
18.15 |
15.23 |
17.48 |
| Sharpe |
-0.15 |
-0.04 |
3.00 |
Shareholder Information
|
| Manager |
Team Managed |
| Since |
N/A |
| Manager Rating * SEE EXPLANTION |
N/A |
| Inception Date |
08/06/1997 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$1,000 |
| Minimum Subsequent Investment |
$100 |
| IRA Minimum |
$1000 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
N |
Wire Fee |
N |
Wire Transfer |
N |
Contact Information
|
| Family |
MorgStan |
| Address |
1585 Broadway
New York, NY 10036 |
| Phone |
N/A |
|
Sponsored Links 
